国际免疫药理学 SCIE

期刊简介估计审稿时候： 约2.7个月 约7.5周

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:

• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.

• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.

• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.

• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.

• Agents that activate genes or modify transcription and translation within the immune response.

• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.

• Production, function and regulation of cytokines and their receptors.

• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

《国际免疫药理学》是颁发与免疫学、药理学、细胞因子生物学、免疫疗法、免疫病理学和免疫毒理学堆叠范畴相干的首创研讨论文的首要载体。也接待涵盖这些主题的批评文章。

合适提交的主题资料包含：

• 接纳任何范例的免疫疗法的临床研讨，包含利用：细菌和化学药剂；胸腺激素、搅扰素、淋巴因子等，在移植和癌症、免疫缺点、慢性传染和过敏、炎症或本身免疫性疾病等疾病中的感化。

• 研讨这些药物对免疫才能特定参数和全体临床状况的感化机制。

• 临床前植物研讨和体外研讨免疫加强剂、免疫调理剂、免疫佐剂和其余对到场免疫或过敏反应的细胞有活性的药剂的感化机制。

• 影响淋巴系统的药理化合物、微生物产物和毒理剂及其感化机制。

• 激活基因或点窜免疫反应内转录和翻译的药剂。

• 经由进程免疫或相干路子激活、天生或开释的具备药理活性的物资。

• 细胞因子及其受体。

• 对于免疫反应进程中开释的趋化因子和生物活性因子感化的典范药理学研讨。

《International Immunopharmacology》(国际免疫药理学)编辑部通信体例为ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。